ApexOnco Front Page Recent articles 17 March 2025 Astra gives in vivo Car-T its biggest endorsement The company buys Belgium’s EsoBiotec for $425m. 17 March 2025 Otsuka bids for a seat at the conjugate table The acquisition of Araris follows a 2023 discovery collaboration. 5 November 2024 ASH 2024 preview – Arcellx disappoints An ASH abstract reveals no delayed neurotoxicity, but three deaths, with anito-cel. 4 November 2024 SITC 2024 preview – duelling TIGIT duds Failed trials of vibostolimab and domvanalimab will be unveiled at SITC late-breakers. 1 November 2024 Essa terminates an N-terminal journey After beating "historical" Xtandi masofaniten fails to beat actual Xtandi. 1 November 2024 FDA red and green lights: October 2024 October's US approvals included Scemblix, Vyloy and Itovebi, while Lumakras was delayed. 31 October 2024 The month ahead: November’s upcoming events Conferences ramp up, and ASH abstracts near. 31 October 2024 No SOS for Bayer's SOS1 The group goes after a KRAS-related target on which Boehringer recently gave up. Load More Recent Quick take ASCO 2024 preview – first look at Kelun’s registrational TROP2 dataset 23 May 2024 Vizimpro delivers for Pfizer 21 May 2024 Pivotal Merck/Kelun TROP2 studies seek nearly 10,000 patients 21 May 2024 A second dato-dxd/Tagrisso combo 17 May 2024 US knocks back another Chinese PD-1 entrant 17 May 2024 ESMO Breast Cancer 2024 – Arvinas rises as vepdegestrant stays the same 16 May 2024 Astra holds its own in stage III lung cancer 13 May 2024 Gilead and Arcellx Immagine the future 10 May 2024 iTeos’s TIGIT enters Arcus territory 10 May 2024 Keynote-B21 checks Keytruda’s endometrial advance 9 May 2024 Load More Most Popular